Promotes cell growth, influences cell cycle, enhances migration and invasion, and maintains cancer stem cell traits; activates IFN-γ/STAT1 and TNF-α/NF-κB pathways, influencing OSCC invasion and immune evasion; modulates tumor immune microenvironment by promoting immune cell infiltration and PD-L1 expression. The gene discussed is IFNG; the disease is cancer.